Design and development of Candesartan cilexetil emulsomal drug delivery systems for the effective management of cardiovascular diseases
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2014, Vol 2, Issue 4
Abstract
The main objective of this research work was to formulate candesartan cilexetil emulsomes (AT2 receptor antagonist) for percutaneous administration for sustaining the drug release and reducing the particle size up to nanolevel leading to better therapy. The compatibility studies of candesartan cilexetil, Glyceryl behenate (Campritol), Soyalecithin and the physical mixture were conducted using I.R spectroscopy. The results revealed that the peaks obtained for candesartan cilexetil pure samples and physical mixture were to be compatible and without changes in the functionalities indicating their compatibility. Candesartan cilexetil emulsomes were formulated by varying the concentrations of glyceryl behenate (0.25-1.0%) and Phosphatidylcholine (0.3-1.6%) by employing thin film hydration technique followed by emulsification followed and high speed homogenization. The formulations were found to be reproducible. When subjected to evaluation, formulation F6 possessed the maximum entrapment efficiency. In-vitro permeation studies of candesartan cilexetil emulsomes revealed that the drug release from all the formulations followed First-order kinetics and ascertained peppas mechanism & F5, F6 and F7 ascertained higuchi’s mechanism respectively. Application of Korsmeyer-peppas equation to the data of all the formulations revealed that the mechanism of candesartan cilexetil emulsomes was governed by predominant non-Fickian diffusion and case –II transport. The average particle size rage of optimized formulation was found to be 116.4 nm well within the emulsomal range. The zeta potential value of the optimized formulation was found to be -27.5 mv indicating high negative surface change leading to greater stability. Based on the above statement the formulation F6 was considered as better formulation for the effective management of cardiovascular diseases.
Authors and Affiliations
Malla Vasavi Chandrika, Medarametla Kishore Babu
Keywords
Related Articles
- EP ID EP33235
- DOI -
- Views 276
- Downloads 0
Review on effect of combination drug therapy on diabetes mellitus and its management
Diabetes is a chronic condition associated with abnormally high levels of sugar (glucose) in the blood. Insulin produced by the pancreas lowers blood glucose. Absence or insufficient production of insulin causes diabet...
Novel drug delivery of Minocycline aganist bacteria by using a polymer citric acid macro molecule
The main objective of the study is to synthesis 3rd generation of citric acid dendrimer and by attaching polyethylene glycol for reducing non specific systemic toxicity, increases the circulation time of the drug and s...
PREPARATION, CHARACTERIZATION AND EVALUATION OF OLMESARTAN MEDOXOMIL-Β CYCLODEXTRIN COMPLEXES
Olmesartan medoxomil is a poor water soluble drug. There are numerous approaches available and reported in literature to enhance the solubility of poor water soluble drugs among which cyclodextrin complexation is predo...
Evaluation of anticonvulsant activity of stem bark extract of Tephrosia purpurea
The anticonvulsant potential of Ethanolic extract of stem bark extract of Tephrosia purperia was evaluated in albino mice. The ethanolic extract of stem bark extract of Tephrosia purperia (200 mg/kg and 400 mg/kg), was...
Formulation and in-vitro evaluation of Aceclofenac loaded topical Emulgel
Gels are a relatively newer class of dosage form created by entrapment of large amounts of aqueous or hydro alcoholic liquid in a network of colloidal solid particles. Gel formulations generally provide faster drug rele...